SCHEMBL4279552

SCHEMBL4279552

OC[C@H]1O[C@H](O)[C@H](OCc2ccccc2)[C@@H](O)[C@@H]1O

nearest known ligand 0.56

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.56
PDE4D Q08499 1/20 0.45
SLC5A2 P31639 3/20 0.45
HRAS P01112 2/20 0.44
LGALS8 O00214 1/20 0.44
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
SLC29A1 Q99808 1/20 0.42
PDPK1 O15530 1/20 0.42
MTOR P42345 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17080335 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL8517368 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL9001315 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL9849302 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL7638059 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL5265599 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL117780 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL5674181 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL8517068 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL8418092 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0613478-A1 IMMUNOSTIMULATING SWAINSONINE ANALOGS TORONTO RESEARCH CHEMICALS INC. (CA) 1994-09-07 EP claimed
WO-1993009117-A1 IMMUNOSTIMULATING SWAINSONINE ANALOGS TORONTO RESEARCH CHEMICALS INC. (CA) 1993-05-13 WO claimed
WO-2020232194-A1 METHODS FOR GLYCOSYLATION THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2020-11-19 WO disclosed
CN-109912642-A Method for stereoselective synthesis of β -2-deoxyglycosidic bond 四川轻化工大学 2019-06-21 CN disclosed
US-8802401-B2 Methods and compositions for preparation of selectively protected carbohydrates THE CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-08-12 US disclosed
US-20090124515-A1 METHODS AND COMPOSITIONS FOR PREPARATION OF SELECTIVELY PROTECTED CARBOHYDRATES THE CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2009-05-14 US disclosed
US-6335464-B1 Process for selectively oxidizing primary hydroxyl groups of organic compounds, and resin containing adsorbed catalyst for use therein CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-01-01 US disclosed
US-6310200-B1 COMPRISING CARBOXYLATION OF AN OLIGOSACCHARIDE USING A DI-TERT-ALKYL NITROXYL FREE RADICAL AS CATALYST AND 1,3-DIBROMO OR -CHLORO-5,5-DI-METHYLHYDANTOIN AS OXIDIZERS AT A PH OF 7-1O; EFFICIENCY AKZO NOBEL N.V. (NL) 2001-10-30 US disclosed
EP-1027931-A1 PROCESS FOR SELECTIVELY OXIDIZING PRIMARY HYDROXYL GROUPS OF ORGANIC COMPOUNDS, AND RESIN CONTAINING ADSORBED CATALYST FOR USE THEREIN CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-08-16 EP disclosed
EP-0829104-A1 HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1998-03-18 EP disclosed
US-5633261-A ANTITUMOR AGENTS TORONTO RESEARCH CHEMICALS, INC. (CA) 1997-05-27 US disclosed
US-5621106-A REACTING WITH DIALKYLTIN OXIDE; ACYLATION; ALKYLATION TORONTO RESEARCH CHEMICALS, INC. (CA) 1997-04-15 US disclosed
WO-1996035239-A1 HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1996-11-07 WO disclosed
US-5466809-A From aminomannose, antitumor agents, castanospermine TORONTO RESEARCH CHEMICALS, INC. (CA) 1995-11-14 US disclosed
EP-0613478-A1 IMMUNOSTIMULATING SWAINSONINE ANALOGS TORONTO RESEARCH CHEMICALS INC. (CA) 1994-09-07 EP disclosed
WO-1993009117-A1 IMMUNOSTIMULATING SWAINSONINE ANALOGS TORONTO RESEARCH CHEMICALS INC. (CA) 1993-05-13 WO disclosed
EP-0415453-A2 Epipodophyllotoxin altroside derivatives Bristol-Myers Squibb Company (US) 1991-03-06 EP disclosed